Icariside F2CAS# 115009-57-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 115009-57-9 | SDF | Download SDF |
| PubChem ID | 14079045 | Appearance | Oil |
| Formula | C18H26O10 | M.Wt | 402.39 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R,3S,4S,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-phenylmethoxyoxane-3,4,5-triol | ||
| SMILES | C1C(C(C(O1)OCC2C(C(C(C(O2)OCC3=CC=CC=C3)O)O)O)O)(CO)O | ||
| Standard InChIKey | NJMQSVWMCODQIP-FQXXIRCGSA-N | ||
| Standard InChI | InChI=1S/C18H26O10/c19-8-18(24)9-27-17(15(18)23)26-7-11-12(20)13(21)14(22)16(28-11)25-6-10-4-2-1-3-5-10/h1-5,11-17,19-24H,6-9H2/t11-,12-,13+,14-,15+,16-,17-,18-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Icariside F2 displays potent NF-κB inhibitory effects, with the IC50 value of 16.25 ± 2.19 uM. 2. Icariside F2 shows modest α-glucosidase inhibitory (4.60±1.74% to 11.97±3.30%) and antioxidant activities. |
| Targets | NF-kB |
Icariside F2 Dilution Calculator
Icariside F2 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.4852 mL | 12.4258 mL | 24.8515 mL | 49.703 mL | 62.1288 mL |
| 5 mM | 0.497 mL | 2.4852 mL | 4.9703 mL | 9.9406 mL | 12.4258 mL |
| 10 mM | 0.2485 mL | 1.2426 mL | 2.4852 mL | 4.9703 mL | 6.2129 mL |
| 50 mM | 0.0497 mL | 0.2485 mL | 0.497 mL | 0.9941 mL | 1.2426 mL |
| 100 mM | 0.0249 mL | 0.1243 mL | 0.2485 mL | 0.497 mL | 0.6213 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Cyclo(L-Leu-trans-4-hydroxy-L-Pro)
Catalog No.:BCN3994
CAS No.:115006-86-5
- 9-Phenylcarbazole
Catalog No.:BCN2259
CAS No.:1150-62-5
- Linalyl Acetate
Catalog No.:BCC8200
CAS No.:115-95-7
- Ambenonium dichloride
Catalog No.:BCC6630
CAS No.:115-79-7
- Sinomenine
Catalog No.:BCN6265
CAS No.:115-53-7
- Azacyclonol
Catalog No.:BCC4761
CAS No.:115-46-8
- Bromophenol Blue
Catalog No.:BCC8029
CAS No.:115-39-9
- Docetaxel
Catalog No.:BCN5342
CAS No.:114977-28-5
- XL-888
Catalog No.:BCC2339
CAS No.:1149705-71-4
- N1,N10-Bis(p-coumaroyl)spermidine
Catalog No.:BCN6027
CAS No.:114916-05-1
- 2-Chloro-1-(5'-(prop-1-ynyl)-2,2'-bithiophen-5-yl)ethanol
Catalog No.:BCN1614
CAS No.:114916-00-6
- Docetaxel intermediate
Catalog No.:BCN8360
CAS No.:114915-14-9
- SR 16584
Catalog No.:BCC6176
CAS No.:1150153-86-8
- Pseudolaric acid D
Catalog No.:BCN6028
CAS No.:115028-67-6
- 29-Norcycloart-23-ene-3,25-diol
Catalog No.:BCN4727
CAS No.:115040-04-5
- Desmethylxanthohumol
Catalog No.:BCN2997
CAS No.:115063-39-3
- CNQX
Catalog No.:BCC6569
CAS No.:115066-14-3
- Soyacerebroside II
Catalog No.:BCN6029
CAS No.:115074-93-6
- Carmoxirole hydrochloride
Catalog No.:BCC7278
CAS No.:115092-85-8
- Tiagabine
Catalog No.:BCC5243
CAS No.:115103-54-3
- MK-571 sodium salt hydrate
Catalog No.:BCC8076
CAS No.:115103-85-0
- MK 571
Catalog No.:BCC7334
CAS No.:115104-28-4
- Antagonist G
Catalog No.:BCC5858
CAS No.:115150-59-9
- Boc-D-Lys(Fmoc)-OH
Catalog No.:BCC3422
CAS No.:115186-31-7
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and alpha-glucosidase inhibitory activity.[Pubmed:25127165]
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4120-4.
Two new compounds, piperoside (1) and isoheptanol 2(S)-O-beta-D-xylopyranosyl (1-->6)-O-beta-D-glucopyranoside (11), along with 10 known compounds 3,4-dihydroxyallylbenzene (2), 1,2-di-O-beta-D-glucopyranosyl-4-allylbenzene (3), tachioside (4), benzyl-O-beta-D-glucopyranoside (5), Icariside F2 (6), dihydrovomifoliol-3'-O-beta-D-glucopyranoside (7), isopropyl O-beta-D-glucopyranoside (8), isopropyl primeveroside (9), n-butyl O-beta-D-glucopyranoside (10), isoheptanol 2(S)-O-beta-D-apiofuranosyl-(1-->6)-O-beta-D-glucopyranoside (12), were isolated from the leaves of Piper retrofractum. Their structures were determined from 1D-NMR, 2D-NMR, and HR-ESI-MS spectral, a modified Mosher's method, and comparisons with previous reports. All of the isolated compounds showed modest alpha-glucosidase inhibitory (4.60+/-1.74% to 11.97+/-3.30%) and antioxidant activities under the tested conditions.
Soluble epoxide hydrolase inhibitory and anti-inflammatory components from the leaves of Eucommia ulmoides Oliver (duzhong).[Pubmed:25679330]
J Agric Food Chem. 2015 Mar 4;63(8):2198-205.
Eucommia ulmoides leaves have been used as a functional food and drink in China. The purpose of this study was to identify the bioactive constituents with soluble epoxide hydrolase (sEH) inhibitory activity and anti-inflammatory properties. Twenty-seven known compounds (1-27) were isolated from the leaves of E. ulmoides Oliver, and their structures were identified by NMR and ESIMS analysis; three of these, 2,5-dimethoxy-3-glucopyranosyl cinnamic alcohol (11), foliasalacioside E2 (26), and Icariside F2 (27), were obtained from this plant for the first time. Compounds 1-7 exhibited soluble epoxide hydrolase (sEH) inhibitory activity at 100 muM; among them, quercetin (1) and kaempferol (5) displayed potential activities with IC50 values of 22.5 +/- 0.9 and 31.3 +/- 2.6 muM, respectively, with noncompetitive inhibition mode. Nuclear factor kappa B (NF-kappaB) inhibitory activity of the isolated compounds was evaluated by the NF-kappaB liciferase assay in HepG2 cells. Compounds 1, 9, 20, and 27 displayed potent NF-kappaB inhibitory effects, with IC50 values of 15.14 +/- 2.29, 15.23 +/- 2.34, 16.88 +/- 2.17, and 16.25 +/- 2.19 muM, respectively, whereas other compounds showed weak inhibition of NF-kappaB transcriptional activity ranging from 17.54 to 92.6 muM. A structure-activity relationship of flavonoids 1-9 was also discussed. The results obtained in this work might contribute to the understanding of pharmacological activities of E. ulmoides leaves and further investigation on its potential application values for food and drug.
